The previously announced acquisition of DERMAdoctor, LLC by NovaBay® Pharmaceuticals, Inc. has been completed. The Company also stated that it will release financial results for the third quarter of 2021 on Thursday, November 11, 2021, and will host an investor conference call at 4:30 p.m. Eastern time on that day. In the acquisition of DERMAdoctor, the Company was advised by Two Roads Advisors LLC, a boutique investment bank led by John Z. Fang and Rob Cooper.
This press release does not constitute an offer to sell or a solicitation of an offer to buy, and no sales of these securities will be made in any jurisdiction where such an offer, solicitation, or sale would be illegal prior to registration or qualification under such jurisdiction’s securities laws. NovaBay Pharmaceuticals, Inc. is a pharmaceutical firm that develops and sells consumer products for the eyecare and skincare industries that are scientifically designed and clinically validated.
This press release contains forward-looking statements that are based on current expectations, assumptions, estimates, projections, and views held by management. These statements include, but are not limited to, statements about our business strategies and current product offerings, potential future product offerings, including through strategic acquisitions like the acquisition of DERMAdoctor, LLC.